Earlobe Crease as Risk Factors of Acute Myocardial Infarction in Chinese Population

Overview

The purpose of this study is to explore the earlobe crease as a risk factor of acute myocardial infarction (AMI)in the Chinese population, combined with other risk factors, to predict high risk patients with coronary heart disease.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: December 2018

Detailed Description

Primary objectives: Odds ratio and 95% confidence interval of binaural earlobe crease as risk factors of AMI. Secondary objectives: 1. To study the characteristics of different earlobe creases in different gender of the patients with AMI. 2. To analyze the characteristics of earlobe crease in different age groups. 3. To compare the feature of earlobe crease in acute ST elevation myocardial infarction and non ST elevation myocardial infarction. 4. The sensitivity,specificity,positive likelihood ratio and negative likelihood ratio of binaural earlobe crease as risk factors of AMI.

Interventions

  • Other: earlobe crease positive
  • Other: earlobe crease negative

Arms, Groups and Cohorts

  • Initial AMI
    • To study the sensitivity, specificity, positive predictive value, and negative predictive value of different earlobe crease as risk factors of AMI
  • No coronary heart disease
    • To study the characteristics of earlobe crease

Clinical Trial Outcome Measures

Primary Measures

  • Odds ratio(OR,the ratio of the explosure number and non-explosure in case group/ the ratio of the explosure number and non-explosure in control group) and 95% confidence interval were calculated of binaural earlobe crease≥ 7 scores as risk factors of AMI
    • Time Frame: 3 years

Secondary Measures

  • The score of the ELC in different gender of the patients with AMI.
    • Time Frame: 3 years
  • The score of ELC in different age groups.
    • Time Frame: 3 years
  • To compare the score of the ELC in acute ST elevation myocardial infarction and non ST elevation myocardial infarction.
    • Time Frame: 3 years
  • The sensitivity(true positive/true positive+false negative) and specificity(true negative/true negative+false positive) of binaural earlobe crease≥ 7 scores as risk factors of AMI.
    • Time Frame: 3 years
  • Positive likelihood ratio(+LR,sensitivity/1-speccificity)and negative likelihood ratio(-LR,1-sensitivity/specificity)of binaural earlobe crease≥ 7 scores as risk factors of AMI
    • Time Frame: 3 years

Participating in This Clinical Trial

Inclusion Criteria

1. Initial acute myocardial infarction(AMI). 2. Detection of a rise and/or fall of cardiac biomarker values (preferably cardiac troponin(cTn) with at least one value above the 99th percentile upper reference limit(URL)) and with at least one of the following:

  • Symptoms of ischemia – Development of pathologic Q waves in the electrocardiogram (ECG) – New or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB). – Identification of an intracoronary thrombus by angiography or autopsy – Imaging evidence of new loss of viable myocardium or a new regional wall motion abnormality. 3. Type 1 (spontaneous myocardial infarction(MI)) in the third universal definition of MI: MI consequent to a pathologic process in the wall of the coronary artery (eg, plaque erosion/rupture, fissuring, or dissection), resulting in intraluminal thrombus. 4. Infarct related artery (IRA) showed that acute thrombus formation, IRA occlusion or stenosis ≥95%、≥90%~95%、≤90%,thrombolysis in myocardial infarction(TIMI) 0-3 flow. 5. Signed informed consent. Exclusion Criteria:

1. Combined valvular heart disease, cardiomyopathy, blood diseases, skin diseases, rheumatic diseases, ischemic cerebrovascular disease, tumor, etc. 2. Previous myocardial infarction. 3. Previous percutaneous coronary intervention(PCI) and coronary artery bypass graft(CABG). 4. Chronic total occlusion(CTO)lesions. 5. Ear malformation. 6. Ocular diseases. 7. Participating in a clinical study.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Jing Qi
  • Collaborator
    • General Hospital of Shenyang Military Region
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Jing Qi, Principal investigator – Liaoning University of Traditional Chinese Medicine
  • Overall Official(s)
    • Junwen Jiang, Doctor, Principal Investigator, Liaoning University of Traditional Chinese Medecine
  • Overall Contact(s)
    • Jing Qi, Master, saraok@126.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.